Search

Author/Creator Vonghachack, Youthanavanh

1. Efficacy and safety of tribendimidine against Opisthorchis viverrini: two randomised, parallel-group, single-blind, dose-ranging, phase 2 trials. Issue 10 (October 2016)

Authors:
Sayasone, Somphou; Odermatt, Peter; Vonghachack, Youthanavanh; Xayavong, Syda; Senggnam, Kanpaseuth; Duthaler, Urs; Akkhavong, Kongsap; Hattendorf, Jan; Keiser, Jennifer
Journal:
Lancet infectious diseases
Issue:
Volume 16:Issue 10(2016:Oct.)
Page Start:
1145
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of tribendimidine against Opisthorchis viverrini: two randomised, parallel-group, single-blind, dose-ranging, phase 2 trials. Issue 10 (October 2016)

Authors:
Sayasone, Somphou; Odermatt, Peter; Vonghachack, Youthanavanh; Xayavong, Syda; Senggnam, Kanpaseuth; Duthaler, Urs; Akkhavong, Kongsap; Hattendorf, Jan; Keiser, Jennifer
Journal:
Lancet infectious diseases
Issue:
Volume 16:Issue 10(2016:Oct.)
Page Start:
1145
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trial. Issue 2 (February 2018)

Authors:
Sayasone, Somphou; Keiser, Jennifer; Meister, Isabel; Vonghachack, Youthanavanh; Xayavong, Syda; Senggnam, Kanpaseuth; Phongluxa, Khampheng; Hattendorf, Jan; Odermatt, Peter
Journal:
Lancet infectious diseases
Issue:
Volume 18:Issue 2(2018)
Page Start:
155
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗